By
Trending Posts
Sanofi Taps Atomwise in $1B+ AI Drug Pact…
Key Highlights San Francisco — Atomwise, a pioneer in artificial intelligence for small molecule drug discovery, has entered…
How Stryker’s Acquisition of care.ai Strengthens Its Push…
Stryker to acquire care.ai to elevate virtual care workflows and expand its healthcare IT leadership Portage, Michigan –…
AI-Powered Clinical Trials: How Unlearn AI, AbbVie, and…
July 30, 2024 Artificial intelligence (AI) is revolutionizing clinical trials, offering greater efficiency and precision. At the Alzheimer’s…
CytoReason Raises $80M from OurCrowd, NVIDIA, Pfizer &…
New funding will scale CytoReason’s AI platform, expand disease models, and support a new office in Cambridge, MA.…
GSK Partners with Ochre Bio in $37.5 Million…
London, UK – June 12 2024 GSK has entered into a $37.5 million strategic partnership with Ochre Bio…
Sanofi, Formation Bio, and OpenAI Forge Strategic Alliance…
Paris, New York, N.Y., and San Francisco, CA — May 21, 2024 Sanofi, Formation Bio, and OpenAI have…
Recursion Unveils BioHive-2: The World’s Largest AI Supercomputer…
Salt Lake City – May 13, 2024 Recursion Pharmaceuticals, a leading clinical-stage TechBio company, has announced the completion…
How Unlearn AI and APST Research Are Revolutionizing…
December 11, 2024 Enhancing Phase II and III Trials by Increasing Statistical Power and Reducing Sample Sizes Unlearn,…
Can BigHat and Johnson & Johnson’s AI-Driven Antibody…
Key Takeaways A Strategic Leap: BigHat Joins Forces with Johnson & Johnson for Neuroscience InnovationBigHat Biosciences, known for…
Trending Posts
Latest Stories
Can GenepoweRx and MGI Tech’s AI-Driven Genomic Partnership Transform Personalized Medicine in 2025?
Key Highlights: Strategic Alliance to Revolutionize Genomic MedicineIndian AI-driven startup GenepoweRx and China’s MGI Tech…
Bexorg and Biohaven: Can Their AI-Driven Whole-Brain Discovery Platform Revolutionize CNS Drug Development?
Key Highlights: Strategic Collaboration to Transform CNS TherapeuticsBexorg, a techbio innovator focused on decoding the…
Tevogen AI & Microsoft: Will Their AI & Generics Bet—and $10B Asset Strategy—Redefine U.S. Bioinnovation Infrastructure?
Key Highlights HQ Expansion to Power AI, Generics & Biosimilar VisionTevogen Bio Holdings Inc. (Nasdaq:…
AlphaMeld AI and VedTechBio: Can Their AI Alliance Cut Discovery Timelines by 50% Across 3 Liver & Metabolic Programs?
Key Highlights Strategic Alliance to Bridge AI Discovery and Translational ExecutionAlphaMeld Corporation, a global leader…
Gallery
